| Literature DB >> 26389922 |
Michael W Mullowney1, Eoghainín Ó hAinmhire2,3, Urszula Tanouye4, Joanna E Burdette5,6, Van Cuong Pham7, Brian T Murphy8,9.
Abstract
A screening of our actinomycete fraction library against the NCI-60 SKOV3 human tumor cell line led to the isolation of isopimara-2-one-3-ol-8,15-diene (1), lagumycin B (2), dehydrorabelomycin (3), phenanthroviridone (4), and WS-5995 A (5). These secondary metabolites were produced by a Micromonospora sp. isolated from sediment collected off the Cát Bà peninsula in the East Sea of Vietnam. Compound 1 is a novel Δ(8,9)-pimarane diterpene, representing one of approximately 20 actinomycete-produced diterpenes reported to date, while compound 2 is an angucycline antibiotic that has yet to receive formal characterization. The structures of 1 and 2 were elucidated by combined NMR and MS analysis and the absolute configuration of 1 was assigned by analysis of NOESY NMR and CD spectroscopic data. Compounds 2-5 exhibited varying degrees of cytotoxicity against a panel of cancerous and non-cancerous cell lines. Overall, this study highlights our collaborative efforts to discover novel biologically active molecules from the large, underexplored, and biodiversity-rich waters of Vietnam's East Sea.Entities:
Keywords: Micromonospora; Vietnam; actinomycete; diterpene; marine; ovarian cancer
Mesh:
Substances:
Year: 2015 PMID: 26389922 PMCID: PMC4584356 DOI: 10.3390/md13095815
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–5.
1H and 13C NMR data (CDCl3) of 1.
| Position | 13C, Type | 1H, Mult. ( |
|---|---|---|
| 1ax | 49.8, CH2 | 2.25, d (12.3) |
| 1eq | 2.58, d (12.3) | |
| 2 | 211.8,C | |
| 3 | 83.0, CH | 3.91, d (4.0) |
| 3-OH | 3.44, d (4.0) | |
| 4 | 45.3, C | |
| 5 | 50.3, CH | 1.78, m |
| 6 | 18.8, CH2 | 1.58, m |
| 1.80, m | ||
| 7 | 32.3, CH2 | 2.03, m |
| 8 | 126.4, C | |
| 9 | 134.3, C | |
| 10 | 43.8, C | |
| 11ax | 21.4, CH2 | 1.76, m |
| 11eq | 1.88, m | |
| 12eq | 34.8, CH2 | 1.33, m |
| 12ax | 1.53, m | |
| 13 | 35.3, C | |
| 14 | 41.6, CH2 | 1.76, m |
| 1.88, m | ||
| 15 | 145.9, CH | 5.72, dd (17.5, 10.7) |
| 16 | 111.2, CH2 | 4.85, dd (17.5, 1.4) |
| 4.92, dd (10.7, 1.4) | ||
| 17 | 28.3, CH3 | 0.98, s |
| 18 | 20.6, CH3 | 0.93, s |
| 19 | 29.3, CH3 | 1.21, s |
| 20 | 16.5, CH3 | 0.72, s |
226.2 MHz; 600 MHz; s = singlet; d = doublet; dd = doublet of doublets; m = multiplet.
Figure 2Key 2D NMR correlations of 1 and 2.
1H and 13C NMR data (CDCl3) of 2.
| Position | 13C, Type | 1H, Mult. ( |
|---|---|---|
| 1 | 154.5, C | |
| 1-OH | 10.45, s | |
| 2 | 121.1, CH | 6.85, s |
| 3 | 143.7, C | |
| 4 | 118.2, CH | 6.54, s |
| 4a | 130.3, C | |
| 5 | 70.7, CH2 | 5.19, s |
| 6a | 157.0, C | |
| 7 | 183.4, C | |
| 7a | 113.5, C | |
| 8 | 161.7, C | |
| 8-OH | 11.70, s | |
| 9 | 125.2, CH | 7.30, d (8.1) |
| 10 | 137.2, CH | 7.66, t (8.1) |
| 11 | 121.3, CH | 7.81, d (8.1) |
| 11a | 132.2, C | |
| 12 | 186.6, C | |
| 12a | 124.4, C | |
| 12b | 109.9, C | |
| 13 | 21.3, CH3 | 2.33, s |
226.2 MHz; 600 MHz; s = singlet; d = doublet; t = triplet.
In vitro cytotoxicity of 1–5.
| Compound | Cytotoxicity LC50 (µM) | |||
|---|---|---|---|---|
| Kuramochi | OVCAR4 | MOSE | MOE | |
| >33.1 | >33.1 | >33.1 | >33.1 | |
| >32.5 | >32.5 | 9.80 | 10.8 | |
| 6.72 | 11.0 | 3.50 | 28.5 | |
| 1.11 | 4.82 | 2.85 | 6.20 | |
| 18.6 | 127 | >149 | >149 | |
Doxorubicin was used as the positive control and was lethal at the lowest concentration tested (0.078 µM).